Finding 636130 (2022-002)

Material Weakness
Requirement
P
Questioned Costs
-
Year
2022
Accepted
2023-06-29

AI Summary

  • Core Issue: There was a material weakness in the reporting of expenditures on the SEFA for the HRSA COVID-19 program, leading to incorrect amounts being reported.
  • Impacted Requirements: Internal controls were inadequate as per 2 CFR Section 200.303, which mandates effective management of federal awards to ensure compliance.
  • Recommended Follow-Up: Management should improve internal controls for accurate reporting and is expanding the Grants Management Finance team to enhance grant tracking and compliance.

Finding Text

Finding 2022-002 ? Material weakness over amounts reported on the Schedule of Expenditures of Federal Awards (SEFA) Identification of the federal program: Assistance Listing Number 93.461: ? COVID-19 ? HRSA COVID-19 Claims Reimbursement for the Uninsured Program and the COVID-19 Coverage Assistance Fund ? U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) ? Federal award identification number ? Various ? Federal award year ?October 1, 2021 through September 30, 2022 Criteria or specific requirement: 2 CFR Section 200.303 of the Uniform Guidance states the following regarding internal control: ?The non-Federal entity must: (a) Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in ?Standards for Internal Control in the Federal Government? issued by the Comptroller General of the United States or the ?Internal Control Integrated Framework?, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).? Condition: The preliminary SEFA expenditures for the HRSA COVID-19 Claims Reimbursement for the Uninsured program incorrectly included claims reimbursements which were later refunded to HRSA, did not appropriately cut off transactions based on date of service for the year ended September 30, 2022, and incorrectly excluded HRSA COVID-19 claims reimbursements received by Champlain Valley Physicians Hospital. Cause: Management did not have effective internal controls in place to ensure accurate reporting of the payments received for the HRSA COVID-19 Claims Reimbursement for the Uninsured program. Effect or potential effect: The payments were incorrected reported in the preliminary SEFA for the year ended September 30, 2022. Questioned costs: None. Context: A preliminary version of the SEFA prepared by management included expenditures for the HRSA COVID-19 Claims Reimbursement for the Uninsured program of $524,543. After commencement of the Uniform Guidance audit procedures and resolution of the issues noted above, adjustments of ($201,253) were made to correct the SEFA expenditures to $323,290. Identification as a repeat finding, if applicable: No. Recommendation: Management should reassess its internal controls over reporting of the payments received for the HRSA COVID-19 Claims Reimbursement for the Uninsured program. Views of responsible individuals: Management agrees with finding as noted above. Management notes that this program is complete, and expenditures will not be incurred nor included on the SEFA in future years. However, management acknowledges the need for complete and accurate reporting on the SEFA. The Network Grants Management Finance team is expanding to work toward centralization of grant tracking. Management has budgeted for an additional FTE within the GMF team in FY23 to engage in this work to centralize grant tracking, which will continue to enhance our controls to ensure completeness and accuracy of the consolidated Network Schedule of Expenditures of Federal Awards.

Categories

Reporting

Other Findings in this Audit

  • 59688 2022-002
    Material Weakness
  • 59689 2022-001
    Significant Deficiency
  • 636131 2022-001
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund $50.71M
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $512,018
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $501,123
93.461 Covid-19 Testing for the Uninsured $323,290
97.036 Disaster Grants - Public Assistance (presidentially Declared Disasters) $294,892
93.155 Rural Health Research Centers $256,051
93.940 Hiv Prevention Activities_health Department Based $139,746
93.251 Early Hearing Detection and Intervention $98,965
93.917 Hiv Care Formula Grants $89,675
84.268 Federal Direct Student Loans $76,840
93.253 Poison Center Support and Enhancement Grant $55,077
93.778 Medical Assistance Program $53,965
93.314 Early Hearing Detection and Intervention Information System (ehdi-Is) Surveillance Program $52,129
93.959 Block Grants for Prevention and Treatment of Substance Abuse $51,954
93.870 Maternal, Infant and Early Childhood Home Visiting Grant $41,895
93.575 Child Care and Development Block Grant $41,125
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $41,023
93.889 National Bioterrorism Hospital Preparedness Program $40,000
84.181 Special Education-Grants for Infants and Families $37,199
93.145 Aids Education and Training Centers $36,879
84.063 Federal Pell Grant Program $23,353
93.080 Blood Disorder Program: Prevention, Surveillance, and Research $20,186
10.558 Child and Adult Care Food Program $16,616
93.110 Maternal and Child Health Federal Consolidated Programs $13,566
93.301 Small Rural Hospital Improvement Grant Program $12,836
93.070 Environmental Public Health and Emergency Response $6,283
93.865 Child Health and Human Development Extramural Research $4,106
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $3,036
93.994 Maternal and Child Health Services Block Grant to the States $681